Omeros (OMER) Income towards Parent Company (2010 - 2026)

Omeros (OMER) reported Income towards Parent Company of $4.8 million for Q1 2026, up 17.2% on a YoY basis from $4.1 million in Q1 2025, and down 26.67% sequentially from $6.6 million in Q4 2025.

Omeros (OMER) Income towards Parent Company (2010 - 2026) Analysis & Trends

Omeros (OMER) has 17 years of Income towards Parent Company data on file, last reported at $4.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 17.2% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 90.69% YoY), and the FY2025 full-year result was $1.5 million, down 94.35% from the prior year.
  • Income towards Parent Company declined to $4.8 million in Q1 2026, from $6.6 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $174.8 million in Q4 2022 to a low of -$9.7 million in Q3 2025.
  • A 5-year average of $18.7 million and a median of $6.6 million in 2025 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 73.05% in 2022 and sank 298.2% in 2025, its largest moves.
  • Tracing OMER's Income towards Parent Company over 5 years: stood at $174.8 million in 2022, then slumped by 82.71% to $30.2 million in 2023, then sank by 82.85% to $5.2 million in 2024, then grew by 26.59% to $6.6 million in 2025, then dropped by 26.67% to $4.8 million in 2026.
  • Business Quant data shows OMER's Income towards Parent Company at $4.8 million in Q1 2026, $6.6 million in Q4 2025, and -$9.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.81 Mn
Dec 31, 2025 6.56 Mn
Sep 30, 2025 -9.67 Mn
Jun 30, 2025 466,000.00
Mar 31, 2025 4.11 Mn
Dec 31, 2024 5.18 Mn
Sep 30, 2024 4.88 Mn
Jun 30, 2024 9.08 Mn
Mar 31, 2024 6.67 Mn
Dec 31, 2023 30.22 Mn
Sep 30, 2023 13.91 Mn
Jun 30, 2023 7.00 Mn
Mar 31, 2023 5.98 Mn
Dec 31, 2022 174.78 Mn
Sep 30, 2022 37.34 Mn
Jun 30, 2022 10.85 Mn
Mar 31, 2022 6.48 Mn
Dec 31, 2021 328.94 Mn
Sep 30, 2021 21.58 Mn
Jun 30, 2021 21.59 Mn